One More Step for Computed Tomography Coronary Angiography Before Heart Valve Surgery
Author(s) -
Patrick T. O’Gara
Publication year - 2009
Publication title -
circulation cardiovascular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.584
H-Index - 99
eISSN - 1942-0080
pISSN - 1941-9651
DOI - 10.1161/circimaging.109.878884
Subject(s) - medicine , computed tomography , coronary angiography , computed tomography angiography , radiology , angiography , cardiology , tomography , heart valve , myocardial infarction
Coronary angiography (CA) to screen for the presence of coronary artery disease (CAD) is routinely performed before elective heart valve surgery. Its use is liberally advocated across a wide spectrum of patients by the writing committees for the treatment of patients with valvular heart disease (VHD) of the American College of Cardiology/American Heart Association and the European Society of Cardiology.1,2 Class I indications, all with level of evidence C, include men 35 to 40 years or older, postmenopausal women, and premenopausal women with coronary risk factors, in addition to the more traditional considerations of suspected myocardial ischemia, left ventricular systolic dysfunction, and any history or other signs of CAD. These recommendations are predicted on 2 major factors; namely, that clinical, ECG, echocardiographic, and radionuclide markers are less specific for CAD in the setting of severe VHD and that perioperative and long-term outcomes are improved in patients with significant CAD undergoing combined valve and coronary bypass surgery compared with patients in whom revascularization is not performed. The evidence base for this latter claim derives primarily from older, single-center observational studies in patients with aortic stenosis (AS) and CAD.3,4 The more recent application of “hybrid” percutaneous coronary intervention with less invasive valvular heart surgery is gaining increasing acceptance,5 though there remains concern regarding the hazards and timing of dual antiplatelet therapy and institutional practices vary widely.Article see p 306 Technological advancements over the past 3 decades now allow for the safe and effective diagnosis and treatment of a variety of cardiovascular disorders using noninvasive or minimally invasive approaches. Lower procedural risks, faster recovery times, shorter hospital stays, reduced costs, and improved patient satisfaction underscore the increasing value of these innovations. As limited examples, consider the currently accepted roles of Doppler echocardiography for the evaluation of patients with valvular …
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom